Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.
Explore this paper's citation graph
Summary
Ischemic complications of coronary angioplasty and atherectomy were reduced with a monoclonal antibody directed against the platelet IIb/IIIa glycoprotein receptor, although the risk of bleeding was increased.
- Type
- article
- Published
- 1994-04-07
- Cited by
- 2,571
- References
- 32
- Access
- Open access
- OpenAlex
- https://openalex.org/W3022148767
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:31685111
Keywords
Medicine, Platelet, Angioplasty, Monoclonal antibody, Tirofiban
References
- Inhibition of dog platelet function by in vivo infusion of F(ab')2 fragments of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor.
- The declining risk of post-transfusion hepatitis C virus infection.
- Left ventricular ejection fraction may not be useful as an end point of thrombolytic therapy comparative trials.
- Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management.
- Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty.
- Randomized Trial of a GPIIb/IIIa Platelet Receptor Blocker in Refractory Unstable Angina
- Changes in myoglobin, creatine kinase and creatine kinase-MB after percutaneous transluminal coronary angioplasty for stable angina pectoris.
- Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent post-angioplasty restenosis and thrombosis.
- Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy.
- Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
- Does the AHA/ACC task force grading system predict outcome in multivessel coronary angioplasty?
- Adequate heparinization during PTCA: assessment using activated clotting times.
- Paucity of subtle myocardial injury after angioplasty delineated with MB CK.
- Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile.
- Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy. The TAMI Study Group.
- Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.
- Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.
- Safety and antiplatelet effect of murine monoclonal antibody 7E3 Fab directed against platelet glycoprotein llb/llla in patients undergoing elective coronary angioplasty
- Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty.
- Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.
Cited by
- In-hospital cost of percutaneous coronary revascularization. Critical determinants and implications.
- Pathobiology of intimal hyperplasia
- Coronary stenting for failed angioplasty in acute myocardial infarction.
- YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice.
- Does intracoronary thrombus influence the outcome of high risk percutaneous transluminal coronary angioplasty? Clinical and angiographic outcomes in a large multicenter trial. EPIC Investigators. Evaluation of IIb/IIIa Platelet Receptor Antagonist 7E3 in Preventing Ischemic Complications.
- Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries.
- In vitro release of vascular endothelial growth factor during platelet aggregation.
- New antiplatelet agents.
- Coronary stenting and use of abciximab.
- Orgaran during rotational atherectomy in the setting of heparin-induced thrombocytopenia.
- Use of abciximab: Comparative economic data☆☆☆★
- Pathophysiology and clinical significance of atherosclerotic plaque rupture.
- Primary stenting in acute myocardial infarction: A 30‐day follow up study
- Interesting cases from the University of Texas Medical Branch.
- Reduced progression of atherosclerosis in apolipoprotein E-deficient mice with phenylhydrazine-induced anemia.
- Applications of Anti-Platelet Monitoring in Catheterization Laboratory
- Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?
- Trial of abciximab with and without low-dose reteplase for acute myocardial infarction. Strategies for Patency Enhancement in the Emergency Department (SPEED) Group.
- Combination of a Direct Thrombin Inhibitor and a Platelet Glycoprotein IIb/IIIa Blocking Peptide Facilitates and Maintains Reperfusion of Platelet-Rich Thrombus with Alteplase
- Facilitated percutaneous coronary intervention: a novel concept in expediting and improving acute myocardial infarction care.
Related papers
- The expression of glycoproteins on single blood platelets from healthy individuals and from patients with congenital bleeding disorders.
- Characteristics of a Neutralizing Monoclonal Antibody to the HIV Envelope Glycoprotein
- Evidence for abnormal platelet glycoprotein expression in diabetes mellitus
- Monocytes and platelets share the glycoproteins IIb and IIIa that are absent from both cells in Glanzmann's thrombasthenia type I.
- Antigenic Properties And Structure Of Membrane Glycoprotein Receptors
- Platelet glycoprotein concentrations in patients with chronic uraemia.
- Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia
- MONOCLONAL ANTIBODIES AGAINST ANTIGENS OF THE HUMAN PLATELET SURFACE: PREPARATION AND PROPERTIES